| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 15/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Safinamide methanesulfonate was approved in February 2015 by the EMA for the treatment of mid- to late-stage fluctuating Parkinson's disease. This approval included use of the drug as an add-on therapy for use with levodopa, either alone or in combination with other existing therapies for Parkinson's disease.51 Safinamide methanesulfonate, an oral α-aminoamide originally discovered by Farmitalia Carlo Erba and later developed by Newron/Zambon.
| Product Name: | Safinamide mesylate |
| Chemical name: | SafinaMideMethanesulfonate |
| CAS No.: | 202825-46-5 |
| Molecular formula: | C17H19FN2O2.CH4O3S |
| Appearance: | White Powder |
| Storage: | Store in a dry and cool place. |
| Shelf life: | 2 years |
| Package: | 25kgs/drum, 1kg/Aluminum foil bags |
Shanghai NORKY PHARMACEUTICAL Co., Ltd., founded in 2006, is a leading manufacturer and supplier of Active Pharmaceutical Ingredients(APIs) and intermediates with a uniquely broad spectrum of innovative products and high quality. We are active in the development, manufacturing and
marketing of APIs and intermediates produced in our manufacturing facility in China under cGMP Compliance.
Our products are mainly focus on Nutritional supplement, food additive, feed additive, Hormones, and Amino acid, herbal extracts, API and intermediates, etc.
Our services and products will address our commitment to customers to provide the solutions they need to enhance their pharmaceutical business.
We will continue to explore new technologies and products and bring improvement to our APIs by offering regulatory documentation for our products; Our goal is to deliver high quality products and services on time to meet customers′ specification.
Contact us now and send you inquiry!
){kind=link}